Europe Stem Cell Therapy Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Stem Cell Therapy Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Stem Cell Therapy Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management to Favor the Market Growth
5.1.2 Increasing Funding in Cancer Management To Enhance the Stem Cell Research Will Drive the Market Growth

5.2 Market Opportunities

5.2.1 Use of Induced Pluripotent Stem Cells in Regenerative Medicines to Provide Lucrative Market Opportunity

5.3 Future Trends

5.3.1 Research activities and product innovations are likely to remain key trends in the market.

5.4 Impact of Drivers and Restraints

6. Europe Stem Cell Therapy Market Regional Analysis

6.1 Europe Stem Cell Therapy Market Overview

6.2 Europe Stem Cell Therapy Market Revenue 2020-2028 (US$ Million)

6.3 Europe Stem Cell Therapy Market Forecast Analysis

7. Europe Stem Cell Therapy Market Analysis – by Type

7.1 Adult Stem Cell Therapy

7.1.1 Overview
7.1.2 Adult Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Embryonic Stem Cell Therapy

7.2.1 Overview
7.2.2 Embryonic Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Induced Pluripotent Stem Cell Therapy

7.3.1 Overview
7.3.2 Induced Pluripotent Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Other Stem Cell Therapy

7.4.1 Overview
7.4.2 Other Stem Cell Therapy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Stem Cell Therapy Market Analysis – by Treatment

8.1 Allogeneic

8.1.1 Overview
8.1.2 Allogeneic: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Autologous

8.2.1 Overview
8.2.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Stem Cell Therapy Market Analysis – by Application

9.1 Musculoskeletal

9.1.1 Overview
9.1.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Dermatology

9.2.1 Overview
9.2.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Cardiology

9.3.1 Overview
9.3.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Drug Discovery & Development

9.4.1 Overview
9.4.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Other Applications

9.5.1 Overview
9.5.2 Autologous: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Stem Cell Therapy Market – Europe Analysis

10.1 Europe

10.1.1 Europe Stem Cell Therapy Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 Europe Stem Cell Therapy Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Stem Cell Therapy Market Breakdown, by Type
10.1.1.1.2 UK: Europe Stem Cell Therapy Market Breakdown, by Treatment
10.1.1.1.3 UK: Europe Stem Cell Therapy Market Breakdown, by Application

10.1.1.2 Germany: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Stem Cell Therapy Market Breakdown, by Type
10.1.1.2.2 Germany: Europe Stem Cell Therapy Market Breakdown, by Treatment
10.1.1.2.3 Germany: Europe Stem Cell Therapy Market Breakdown, by Application

10.1.1.3 France: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Stem Cell Therapy Market Breakdown, by Type
10.1.1.3.2 France: Europe Stem Cell Therapy Market Breakdown, by Treatment
10.1.1.3.3 France: Europe Stem Cell Therapy Market Breakdown, by Application

10.1.1.4 Russia: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Stem Cell Therapy Market Breakdown, by Type
10.1.1.4.2 Russia: Europe Stem Cell Therapy Market Breakdown, by Treatment
10.1.1.4.3 Russia: Europe Stem Cell Therapy Market Breakdown, by Application

10.1.1.5 Italy: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Stem Cell Therapy Market Breakdown, by Type
10.1.1.5.2 Italy: Europe Stem Cell Therapy Market Breakdown, by Treatment
10.1.1.5.3 Italy: Europe Stem Cell Therapy Market Breakdown, by Application

10.1.1.6 Rest of Europe: Europe Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Stem Cell Therapy Market Breakdown, by Type
10.1.1.6.2 Rest of Europe: Europe Stem Cell Therapy Market Breakdown, by Treatment
10.1.1.6.3 Rest of Europe: Europe Stem Cell Therapy Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Stem Cell Therapy Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 MEDIPOST

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 BioTime, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Mesoblast Limited

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 TiGenix NV

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 NuVasive Inc

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Holostem Terapie Avanzate Srl

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights